Dr. Rebecca L. Aft, MD

Dr. Aft practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Aft's NPI, 1164440897, was assigned on July 18, 2006. Dr. Aft graduated from Washington University School of Medicine in 1992. Dr. Aft holds Missouri license 101027.

Dr. Aft's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Aft also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Aft's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Aft is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Aft to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aft practices, 5 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Aft's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Aft is licensed in Missouri.

CMS data shows 226 Medicare services from Dr. Aft across 8 procedure codes in 2024, for 129 Medicare patients. Medicare paid $50,822 for them.

CMS counts 129 Medicare patients who saw Dr. Aft in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have cancer, and 74% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Aft's median patient age at 66, with 95% women.

In 2024, Dr. Aft wrote 228 Medicare Part D claims for 80 patients. 100% of them were for generic drugs. CMS names the drug for 209 of them, across 5 drugs with 11 or more claims each, at $2,705 in total drug cost. In 2023, CMS named 155 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Aft for performance year 2024, reported as part of a group. Dr. Aft accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 55 procedures of mastectomy by Dr. Aft, more than 95% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 66 papers to Dr. Aft, published from 2010 to 2024. 2017 was the busiest year, with 6. The most frequent topics are Breast Neoplasms, Biomarkers, Tumor and Carcinoma, Ductal, Breast. Dr. Aft has published most often in Breast Cancer Res Treat. Dr. Aft's most frequent co-authors are Julie A. Margenthaler, MD, William E. Gillanders, MD and Amy Elizabeth Cyr, MD.

Dmand AI links Dr. Aft to 11 clinical trials, 3 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Triple Negative Breast Neoplasms. Washington University School of Medicine sponsors the most, 5. Open Payments lists research payments to Dr. Aft that name 1 trial.

CMS Open Payments shows 43 general payments to Dr. Aft from 4 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 74% of the total. Intuitive Surgical, Inc. paid the most, $8,430. It also lists 2 research payments totaling $807 from 2021 to 2022, naming 1 clinical trial.

Dr. Aft graduated from Washington University School of Medicine in 1992.